Surgical resection of brain metastases remains their cornerstone treatment. Recently, there has been a growing interest in systemic targeted therapy along with methods for local control of the disease. This is especially true in the case of multiple metastases when a surgical procedure cannot be performed because of the dissemination of a tumor process. The paper describes the experience with targeted BRAF inhibitor therapy in a patient with multiple melanoma brain metastases.